CAI FY 2019 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$417M-3.6% YoY

Gross Profit

$201M48.1% margin

Operating Income

$130M31.3% margin

Net Income

$31M7.4% margin

EPS (Diluted)

$1.72

Cash Flow

Operating Cash Flow

$254M

Free Cash Flow

-$65M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$2.9B

Total Liabilities

$2.2B

Stockholders' Equity

$693M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$417M	$432M	-3.6%
Gross Profit	$201M	$214M	-6.1%
Operating Income	$130M	$149M	-12.4%
Net Income	$31M	$79M	-60.5%